Pacific Biosciences Of California (PACB) Change in Accured Expenses (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Change in Accured Expenses of $5.1 million for Q1 2026, up 118.76% year-over-year from $2.3 million in Q1 2025, and up 400.19% quarter-over-quarter from $1.0 million in Q4 2025.
Pacific Biosciences Of California (PACB) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $5.1 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 118.76% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $1.6 million (up 755.56% YoY), while the FY2025 annual figure was -$1.2 million, up 95.47% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $5.1 million, up from $1.0 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $22.7 million in Q2 2024, with the low at -$25.6 million in Q3 2024.
- The 5-year median for Change in Accured Expenses is -$1.6 million (2025), against an average of -$761823.5.
- Peak annual rise in Change in Accured Expenses reached 747.36% in 2024, while the deepest fall reached 867.54% in 2024.
- Pacific Biosciences Of California's Change in Accured Expenses stood at -$2.0 million in 2022, then soared by 666.27% to $11.0 million in 2023, then sank by 97.08% to $323000.0 in 2024, then surged by 217.65% to $1.0 million in 2025, then jumped by 400.19% to $5.1 million in 2026.
- Business Quant data shows PACB's Change in Accured Expenses at $5.1 million in Q1 2026, $1.0 million in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn | 734,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 734,000.00 |
| Jun 30, 2026 | 734,000.00 |
| Mar 31, 2026 | 5.13 Mn |
| Mar 31, 2026 | 5.13 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | -1.59 Mn |
| Sep 30, 2025 | -1.59 Mn |
| Jun 30, 2025 | -2.98 Mn |
| Jun 30, 2025 | -2.98 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 323,000.00 |
| Dec 31, 2024 | 323,000.00 |
| Sep 30, 2024 | -25.58 Mn |
| Sep 30, 2024 | -25.58 Mn |
| Jun 30, 2024 | 22.66 Mn |
| Jun 30, 2024 | 22.66 Mn |
| Mar 31, 2024 | -23.75 Mn |
| Mar 31, 2024 | -23.75 Mn |